Aster Capital Management (Difc) LTD Rezolute, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $262 Billion
- Q4 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Rezolute, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 25,078 shares of RZLT stock, worth $117,866. This represents 0.05% of its overall portfolio holdings.
Number of Shares
25,078
Previous 25,078
-0.0%
Holding current value
$117,866
Previous $122 Million
1.03%
% of portfolio
0.05%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding RZLT
# of Institutions
76Shares Held
44.6MCall Options Held
201KPut Options Held
2.8K-
Federated Hermes, Inc. Pittsburgh, PA11.3MShares$53 Million0.13% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.86MShares$13.4 Million0.69% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.8MShares$13.1 Million2.6% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.53MShares$11.9 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.32MShares$10.9 Million0.0% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $182M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...